Yi Bao
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
Papers in
-
- Renal Transplantation Outcomes and Treatments 3
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 3
Yi Bao
43 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 787
- Molecular Biology 1.2k
- Transplantation 44
- Oncology 385
- Pulmonary and Respiratory Medicine 304
Countries citing papers authored by Yi Bao
This map shows the geographic impact of Yi Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Bao more than expected).
Fields of papers citing papers by Yi Bao
This network shows the impact of papers produced by Yi Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Bao. The network helps show where Yi Bao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer Hit paper breakdown → | 2023 | 154 |
| 2 | 2023 | 3 | |
| 3 | 2022 | 14 | |
| 4 | 2019 | 11 | |
| 5 | 2019 | 41 | |
| 6 | 2019 | 150 | |
| 7 | 2019 | 9 | |
| 8 | 2018 | 49 | |
| 9 | 2017 | 41 | |
| 10 | 2017 | 172 | |
| 11 | 2016 | 98 | |
| 12 | 2016 | 28 | |
| 13 | 2015 | 17 | |
| 14 | 2015 | 10 | |
| 15 | 2013 | 28 | |
| 16 | 2013 | 17 | |
| 17 | 2011 | 37 | |
| 18 | 2011 | 62 | |
| 19 | 2011 | 10 | |
| 20 | 1996 | 27 |
About Yi Bao
Yi Bao is a scholar working on Transplantation, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Allergy and Molecular Biology, having authored 44 papers that have together received 1.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Cancer-related molecular mechanisms research (7 papers), Ferroptosis and cancer prognosis (5 papers), Renal and related cancers (5 papers), Circular RNAs in diseases (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), MicroRNA in disease regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Cancer Research (787 citations), Molecular Biology (1.2k citations), Transplantation (44 citations), Oncology (385 citations) and Pulmonary and Respiratory Medicine (304 citations). Yi Bao has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Run Lu, V. L. Schuster, Norifumi Kanai, Zhenjie Wu, Le Qu, Anbang Wang, Linhui Wang, Bing Liu, Tangliang Zhao and Deng-Shuang Wu. Their work appears in journals such as Transplantation, Oncogene, Scientific Reports, Journal of Endourology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.